🔎 Trials Near Me

Akèy › Maladi poumon entèstisyèl › Florid › Orlando

Etid klinik pou Maladi poumon entèstisyèl nan Orlando, FL

9 etid pou Maladi poumon entèstisyèl ap chèche patisipan nan sit nan ak bò kote Orlando (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

Ap rekriteFaz 3
  • Clinical Research Specialists LLC - Kissimmee, Kissimmee · 16 mi lwen
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07540988

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

Ap rekriteFaz 3
  • Clinical Research Specialists LLC - Kissimmee, Kissimmee · 16 mi lwen
Laj 40 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07201922

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Ap rekriteFaz 2
  • Eunix Clinical Research, Orlando
Laj 18 a 80 · Tout sèks · Mizajou Sep 29, 2026 · NCT05798923

A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)

Ap rekriteFaz 3
  • Clinical Research Site, Kissimmee · 16 mi lwen
Laj 18 a 85 · Tout sèks · Mizajou Sep 11, 2026 · NCT07816185

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

Ap rekriteFaz 2
  • Clinical Research Site, Kissimmee · 16 mi lwen
Laj 18 a 85 · Tout sèks · Mizajou Sep 2, 2026 · NCT07333183

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Ap rekriteEtid obsèvasyon
  • Advent Health Medical Group Advanced Lung Disease, Orlando
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06388421

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

Ap rekriteEtid obsèvasyon
  • Advent Health, Orlando
Laj 18 a 80 · Tout sèks · Mizajou Jun 26, 2026 · NCT06129240

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

Ap rekriteFaz 2
  • Central Florida Pulmonary Group, P.A. (CFPG) - Downtown Orlando, Orlando
  • Florida Lung Asthma and Sleep Specialist, Celebration · 17 mi lwen
Laj 40 ak plis · Tout sèks · Mizajou Nov 12, 2025 · NCT05975983

Etid Maladi poumon entèstisyèl nan lòt vil

Lòt etid nan Orlando

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.